Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves

Published:2017-02-14 Issue:7 Volume:135 Page:714-716
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Siontis Konstantinos C.¹,Yao Xiaoxi¹,Gersh Bernard J.¹,Noseworthy Peter A.¹

Affiliation:

1. From Division of Cardiovascular Medicine, University of Michigan, Ann Arbor (K.C.S.); and Division of Health Care Policy and Research, Department of Health Sciences Research (X.Y.) and Division of Cardiovascular Diseases (B.J.G., P.A.N.), Mayo Clinic, Rochester, MN.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.116.026793

Reference5 articles.

1. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

2. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

3. OUTCOMES IN 2824 PATIENTS WITH VALVULAR HEART DISEASE TREATED WITH EDOXABAN OR WARFARIN IN THE ENGAGE AF-TIMI 48 TRIAL

4. Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

5. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanical Aortic Valve Thrombosis During Anticoagulation Using Oral Rivaroxaban: A Case Report;Cureus;2024-07-20

2. Use of Direct‐Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation;Journal of the American Heart Association;2024-02-06

3. Comparing DOACs with warfarin in AF patients with chronic kidney disease or valvular disease: A systematic review and meta-analysis;2024-01-15

4. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2024-01-02

5. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation;Journal of the American College of Cardiology;2024-01